SemiLEDS Corporation (LEDS) News

SemiLEDS Corporation (LEDS): $6.73

0.30 (+4.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter LEDS News Items

LEDS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest LEDS News From Around the Web

Below are the latest news stories about SemiLEDs Corp that investors may wish to consider to help them evaluate LEDS as an investment opportunity.

The World’s First 0.49mm Fine-Pitch Mini-LED Display Panel Using 36 Pixel-in-1 MiniLED πLED Package.

CHUNAN, Taiwan, July 26, 2021--TSLC Corporation, a vertically integrated LED system manufacturer, introduced the world’s first 0.49mm fine-pitch direct-lit display using 36 pixels-in-1 πLED package (Pixels Interconnected LED or πLED). The display is utilized proprietary πLED technology from SemiLEDs Corporation and drivers made by Raffar Technology Corporation. Unlike other fine-pitch miniLED displays in the market, TSLC’s display panel uses SMT process to populate the pixels, enabling exception

Yahoo | July 26, 2021

What Do SemiLEDs’ Risk Factors Tell Investors?

SemiLEDs (LEDS) develops, manufactures, and sells LED chips and LED components for general lighting and specialty industrial applications. Let’s take a look at what has changed in its key risk factors that investors should know, along with its financial performance. According to the new Tipranks Risk Factors tool, SemiLEDs’ main risk category is Finance & Corporate, which accounts for 33% of the total 54 risks identified. The next three major risk factor contributors are Tech & Innovation, Production, and Ability to Sell at 15% each. Since May, the company has changed one key risk factor under the Finance & Corporate category.

Kailas Salunkhe on TipRanks | July 15, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Welcome back, traders!

William White on InvestorPlace | June 8, 2021

10 Best Tech Stocks to Buy Right Now Under $10

In this article, we will take a look at the 10 best tech stocks to buy right now under $10. You can skip our comprehensive analysis of these stocks and go directly to the 5 Best Tech Stocks to Buy Right Now Under $10. Technology firms have witnessed explosive growth over the past few years […]

Yahoo | May 7, 2021

SemiLEDs Reports Second Quarter Fiscal Year 2021 Financial Results

SemiLEDs Corporation (NASDAQ: LEDS), "SemiLEDs" or the "Company," a developer and manufacturer of LED chips and LED components, today announced its financial results for the second quarter of fiscal year 2021, ended February 28, 2021.

Yahoo | April 8, 2021

SemiLEDs to Announce Fiscal Second Quarter 2021 Financial Results on Thursday, April 8, 2021

SemiLEDs Corporation (NASDAQ:LEDS), will report financial results for the 2021 fiscal Second quarter ended February 28, 2021 after market close on Thursday, April 08, 2021.

Yahoo | April 6, 2021

SemiLEDs Reports First Quarter Fiscal Year 2021 Financial Results

SemiLEDs Corporation (NASDAQ: LEDS), "SemiLEDs" or the "Company," a developer and manufacturer of LED chips and LED components, today announced its financial results for the first quarter of fiscal year 2021, ended November 30, 2020.

Yahoo | January 8, 2021

SemiLEDs to Announce Fiscal First Quarter 2021 Financial Results on Friday, January 8, 2021

SemiLEDs Corporation (NASDAQ:LEDS), will report financial results for the 2021 fiscal First quarter ended November 30, 2020 after market close on Friday, January 08, 2021.

Yahoo | January 6, 2021

We're Keeping An Eye On Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | December 15, 2020

TYME Announces SM-88 Abstract Selected for Presentation at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that an abstract highlighting clinical data for TYME's lead candidate, oral SM-88 (racemetyrosine), in patients with metastatic pancreatic cancer, has been selected for poster presentation at the American Society of Clinical Oncology (ASCO) Virtual 2021 Gastrointestinal Cancers Symposium being held on January 15 - 17, 2021.

Yahoo | December 9, 2020


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6211 seconds.